Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus

Lupus

Volumn 23, Issue 9, 2014, Pages 868-875

  Li, Y N ^a   Hu, F L ^a   Dai, Y J ^a   Li, R ^a   Ma, X X ^a   Du, Y ^a   Feng, M ^a   Jia, Y ^a   Zhang, C F ^a   Zhu, L ^a   Ascherman, D P ^b   Li, Z G ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

anti lipocalin IgG; Lipocalin 2; neutrophil gelatinasea associated lipocalin (NGAL); ROC curve; systemic lupus erythematosus (SLE)

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; LIPOCALIN 2 ANTIBODY; NUCLEOSOME ANTIBODY; SM ANTIBODY; UNCLASSIFIED DRUG; ACUTE PHASE PROTEIN; IMMUNOGLOBULIN G; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROPLATE READER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SPECTROPHOTOMETER; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; BLOOD; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; YOUNG ADULT;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; BIOMARKERS; FEMALE; HUMANS; IMMUNOGLOBULIN G; LIPOCALINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; YOUNG ADULT;

EID: 84903766456     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314530484     Document Type: Article

References (19)

1. Lee SJ, Silverman E, Bargman JM. The role of antimalarial agents in the treatment of SLE and lupus nephritis. Nat Rev Nephrol. 2011 ; 7: 718-729
2. Sherer Y, Gorstein A, Fritzler MJ, et al. Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Semin Arthritis Rheum. 2004 ; 34: 501-537
3. Yang J, Goetz D, Li JY, et al. An iron delivery pathway mediated by a lipocalin. Mol Cell. 2002 ; 10: 1045-1056
4. Supavekin S, Zhang W, Kucherlapati R, et al. Differential gene expression following early renal ischemia/reperfusion. Kidney Int. 2003 ; 63: 1714-1724
5. Pitashny M, Schwartz N, Qing X, et al. Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis. Arthritis Rheum. 2007 ; 56: 1894-1903
6. Trachtman H, Christen E, Cnaan A, et al. Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: A novel marker of renal injury. Pediatr Nephrol. 2006 ; 21: 989-994
7. Cowland JB, Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics. 1997 ; 45: 17-23
8. Bennett M, Dent CL, Ma Q, et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: A prospective study. Clin J Am Soc Nephrol. 2008 ; 3: 665-673
9. Brunner HI, Mueller M, Rutherford C, et al. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 2006 ; 54: 2577-2584
10. Hammad A, Mosaad Y, Elhanbly S, et al. Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children. Lupus. 2013 ; 22: 486-491
11. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 ; 31: 315-324
12. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
13. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 ; 61: 554-558
14. Malyszko J, Malyszko JS, Bachorzewska-Gajewska H, et al. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients. Transplant Proc. 2009 ; 41: 158-161
15. Rubinstein T, Pitashny M, Levine B, et al. Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology (Oxford). 2010 ; 49: 960-971
16. Su Y, Jia RL, Han L, et al. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus. Clin Immunol. 2007 ; 122: 115-120
17. Bizzaro N, Villalta D, Giavarina D, et al. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis. Autoimmun Rev. 2012 ; 12: 97-106
18. Li PH, Wong WH, Lee TL, et al. Relationship between autoantibody clustering and clinical subsets in SLE: Cluster and association analyses in Hong Kong Chinese. Rheumatology (Oxford). 2013 ; 52: 337-345
19. Ippolito A, Wallace DJ, Gladman D, et al. Autoantibodies in systemic lupus erythematosus: Comparison of historical and current assessment of seropositivity. Lupus. 2011 ; 20: 250-255